Paths of Progress
Five years after taking part in a clinical trial, 9-year-old Catherine Lyons remain active and healthy.
Fall/Winter 2000
Volume 9, Number 2
Contents
Features
- The True Heroes of Clinical Research
Medical advances depend on patients who take part in clinical trials. This article looks at their reasons for participating and the potential benefits for them and other patients. - Inside the Dana-Farber/Harvard Cancer Center
Supported by a major National Cancer Institute grant, the DF/HCC combines the talents and resources of scientists at seven Harvard-affiliated institutions. Discover the advantages this collaboration offers in the fight against cancer. - Separating Hope from Hype in Cancer Research
How can the public understand progress being made in cancer research and treatment amid sometimes dubious reporting about "breakthroughs" and "cures"? A panel of Dana-Farber clinicians and researchers discusses the issue. - Aging and Cancer: The Unwelcome Passenger
Cancer strikes those over 65 far more often than the young. DFCI researchers are at the forefront of figuring out why and exploring potential prevention strategies.
Departments
- Dateline DFCI
Leadership transition: Edward J. Benz Jr., M.D., will succeed David G. Nathan, M.D., as Dana-Farber's president. - Discoveries
Dana-Farber research updates - A Letter from the President
Credits
President, Dana-Farber Cancer Institute David G. Nathan, M.D.
Chief of Staff Stephen E. Sallan, M.D.
Chair, Adult Oncology Lee M. Nadler, M.D.
Chair, Executive Committee for Research David M. Livingston, M.D.
Chief of Communications Steven R. Singer
Director of Publications/Editor Paul Hennessy
Associate Editor Hilary F. Bennett
Contributors Paul Hennessy, John Lauerman, Robert Levy, Virginia Ross,
Debra Ruder, Cindy Whitcome, Saul Wisnia
Design John DiGianni
Production Assistance Amy Fontaine
Photography C.J. Allen, Steve Gilbert, Shawn Henry, Bill Horseman,
Eugene Richards
Paths of Progress is published twice a year by Dana-Farber Cancer Institute's Department of Communications. If you have any comments or would like to be removed from the mailing list, contact:
Debra Ruder (debra_ruder@dfci.harvard.edu)
Editor, Paths of Progress
Dana-Farber Cancer Institute, Department of Communications
375 Longwood Ave., Boston, MA 02215-5347
(617) 632-4090
Copyright © 2003 Dana-Farber Cancer Institute. All rights reserved.
